Epigallocatechin-3-gallate (EGCG) attenuates non-alcoholic fatty liver disease via modulating the interaction between gut microbiota and bile acids.
J Clin Biochem Nutr
; 67(1): 2-9, 2020 Jul.
Article
in En
| MEDLINE
| ID: mdl-32801462
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Clin Biochem Nutr
Year:
2020
Document type:
Article
Affiliation country:
Japón